Current Report Filing (8-k)
14 September 2022 - 6:16AM
Edgar (US Regulatory)
0000051143
false
Capital stock, par value $.20 per share
IBM
CHX
0000051143
2022-09-13
2022-09-13
0000051143
us-gaap:CommonStockMember
exch:XCHI
2022-09-13
2022-09-13
0000051143
us-gaap:CommonStockMember
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes1.25PercentDue2023Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes0.375PercentDue2023Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes1.125PercentDue2024Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes2.875PercentDue2025Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes0.950PercentDue2025Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes0.875PercentDue2025Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes0.300PercentDue2026Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes1.250PercentDue2027Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes0.300PercentDue2028Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes1.750PercentDue2028Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes1.500PercentDue2029Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes0.875PercentDue2030Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes1.250PercentDue2034Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Notes1.750PercentDue2031Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
exch:XNYS
ibm:Notes0.650PercentDue2032Member
2022-09-13
2022-09-13
0000051143
exch:XNYS
ibm:Notes1.200PercentDie2040Member
2022-09-13
2022-09-13
0000051143
ibm:Debentures7.00PercentDue2025Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Debentures6.22PercentDue2027Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Debentures6.50PercentDue2028Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Debentures5.875PercentDue2032Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Debentures7.00PercentDue2045Member
exch:XNYS
2022-09-13
2022-09-13
0000051143
ibm:Debentures7.125PercentDue2096Member
exch:XNYS
2022-09-13
2022-09-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
| Title of each class |
Capital stock, par value $.20 per share |
| Trading
symbol |
IBM |
|
Common Stock |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: September 13, 2022
(Date of earliest
event reported)
INTERNATIONAL
BUSINESS MACHINES CORPORATION
(Exact name of registrant
as specified in its charter)
| New York |
|
001-2360 |
|
13-0871985 |
| (State or other jurisdiction |
|
(Commission |
|
(IRS employee |
| of incorporation) |
|
File No.) |
|
Indemnification No.) |
One New Orchard Road
|
|
|
| Armonk,
New York |
|
10504 |
| (Address of principal executive offices) |
|
(Zip Code) |
914-499-1900
(Registrant’s telephone number, including area code)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange
on which registered |
| Capital stock, par value $.20 per share |
|
IBM |
|
New York Stock Exchange |
| |
|
|
|
NYSE Chicago |
| 1.250% Notes due 2023 |
|
IBM 23A |
|
New York Stock Exchange |
| 0.375% Notes due 2023 |
|
IBM 23B |
|
New York Stock Exchange |
| 1.125% Notes due 2024 |
|
IBM 24A |
|
New York Stock Exchange |
| 2.875% Notes due 2025 |
|
IBM 25A |
|
New York Stock Exchange |
| 0.950% Notes due 2025 |
|
IBM 25B |
|
New York Stock Exchange |
| 0.875% Notes due 2025 |
|
IBM 25C |
|
New York Stock Exchange |
| 0.300% Notes due 2026 |
|
IBM 26B |
|
New York Stock Exchange |
| 1.250% Notes due 2027 |
|
IBM 27B |
|
New York Stock Exchange |
| 0.300% Notes due 2028 |
|
IBM 28B |
|
New York Stock Exchange |
| 1.750% Notes due 2028 |
|
IBM 28A |
|
New York Stock Exchange |
| 1.500% Notes due 2029 |
|
IBM 29 |
|
New York Stock Exchange |
| 0.875% Notes due 2030 |
|
IBM 30 |
|
New York Stock Exchange |
| 1.750% Notes due 2031 |
|
IBM 31 |
|
New York Stock Exchange |
| 0.650% Notes due 2032 |
|
IBM 32A |
|
New York Stock Exchange |
| 1.250% Notes due 2034 |
|
IBM 34 |
|
New York Stock Exchange |
| 1.200% Notes due 2040 |
|
IBM 40 |
|
New York Stock Exchange |
| 7.00% Debentures due 2025 |
|
IBM 25 |
|
New York Stock Exchange |
| 6.22% Debentures due 2027 |
|
IBM 27 |
|
New York Stock Exchange |
| 6.50% Debentures due 2028 |
|
IBM 28 |
|
New York Stock Exchange |
| 5.875% Debentures due 2032 |
|
IBM 32D |
|
New York Stock Exchange |
| 7.00% Debentures due 2045 |
|
IBM 45 |
|
New York Stock Exchange |
| 7.125% Debentures due 2096 |
|
IBM 96 |
|
New York Stock Exchange |
Indicate by check mark
whether the registrar is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230 405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth
company indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 8.01. Other Events.
On September 7, 2022, International Business Machines
Corporation (“IBM” or the “Company”) and State Street Global Advisors Trust Company, as independent fiduciary
of the IBM Personal Pension Plan (the “Plan”), entered into two separate commitment agreements, one with The Prudential Insurance
Company of America (“Prudential”) and one with Metropolitan Life Insurance Company (collectively, the “Insurers”)
under which the Plan agreed to purchase nonparticipating single premium group annuity contracts that will transfer to the Insurers approximately
$16 billion of the Plan’s defined benefit pension obligations related to certain pension benefits that began to be paid prior to
2016.
The purchase of the group annuity contracts closed
on September 13, 2022. The contracts cover approximately 100,000 IBM participants and beneficiaries (the “Transferred Participants”).
Under the group annuity contracts, each Insurer has made an irrevocable commitment, and will be solely responsible, to pay 50% of the
pension benefits of each Transferred Participant that are due on and after January 1, 2023. Prudential will be the lead administrator.
The transaction will result in no changes to the amount of benefits payable to the Transferred Participants.
The purchase of the group annuity contracts was
funded directly by assets of the Plan and required no cash or asset contributions of the Company. As a result of the transaction, the
Company expects to recognize a one-time non-cash pre-tax pension settlement charge of approximately $5.9 billion ($4.4 billion net of
tax) in the third quarter of 2022. The actual charge will depend on finalization of the actuarial and other assumptions. The pre-tax charge
was not included in the GAAP forward-looking information released on July 18, 2022. This charge will not impact the Company’s third
quarter or full year 2022 operating (non-GAAP) profit or free cash flow.
Forward-Looking Statements
Certain statements contained in this Form 8-K
may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (“Reform
Act”). Forward-looking statements are based on the company’s current assumptions regarding future business and financial performance.
These statements by their nature address matters that are uncertain to different degrees. The company may also make forward-looking statements
in other reports filed with the Securities and Exchange Commission (SEC), in materials delivered to stockholders and in press releases.
In addition, the company’s representatives may from time to time make oral forward-looking statements. Forward-looking statements
provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to
any historical or current fact. Words such as “anticipates,” “believes,” “expects,” “estimates,”
“intends,” “plans,” “projects,” and similar expressions, may identify such forward-looking statements.
Any forward-looking statement in this Form 8-K speaks only as of the date on which it is made. Except as required by law, the company
assumes no obligation to update or revise any forward-looking statements.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. |
|
Description |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: September 13, 2022
| |
INTERNATIONAL BUSINESS MACHINES CORPORATION |
| |
|
| |
By: |
/s/Frank Sedlarcik |
| |
|
Frank Sedlarcik |
| |
|
Vice President, Assistant General Counsel and Secretary |
International Business M... (NYSE:IBM)
Historical Stock Chart
From Mar 2024 to Apr 2024
International Business M... (NYSE:IBM)
Historical Stock Chart
From Apr 2023 to Apr 2024
